Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
darolutamide (Nubeqa) (1 trial)
enzalutamide (xtandi) (2 trials)
radium-223 (xofigo) (1 trial)
bicalutamide (casodex) (1 trial)
Prostatic Neoplasms (Phase 3)
Trials (2 total)
Trial APIs (4 total)